ABT-866
ABT-866 is an α1A-adrenoceptor agonist and an antagonist at the α1B- and α1D-adrenoceptor subtypes. ABT-866 has an EC50 of 0.60 μM for the α1A in the rabbit urethra. ABT-866 has a pA2 value of 5.4 for the α1B in the rat spleen. ABT-866 has a pA2 value of 6.2 for the α1D in the rat aorta. ABT-866 exhibits good urethral selectivity and lower cardiovascular side effects in stress urinary incontinence models. ABT-866 can be used for the research of diseases such as stress urinary incontinence[1][2].
Product Specifications
CAS Number
258526-74-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Adrenergic Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology; Cardiovascular Disease
Smiles
O=S(NC1=CC=CC(CC2=CN=CN2)=C1)(CC)=O
Molecular Formula
C12H15N3O2S
Molecular Weight
265.33
Precautions
P261-P280-P302+P352
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Micalcl sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
![Mouse Monoclonal BATF3 Antibody (841702) [FITC]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
PAX3 (Paired Box Protein Pax-3, HuP2, HUP2, MGC120381, MGC120382, MGC120383, MGC120384, MGC134778) (FITC)